RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
  Anorexia Nervosa
  Anxiety
  Bulimia
  CFS
  Child Psychiatry
  Depression
  Forensic Psychiatry
  Learning-Disabilities
  Mood Disorders
  Neuropsychiatry
  Peri-Natal Psychiatry
  Personality Disorders
  Psychology
  Psychoses
   Bipolar Disorder
   Schizophrenia
  Psychotherapy
  Sleep Disorders
  Substance Abuse
  Suicide
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Schizophrenia Channel

subscribe to Schizophrenia newsletter
Latest Research : Psychiatry : Psychoses : Schizophrenia

   EMAIL   |   PRINT
Effects of ketamine mimic only some of the symptoms of schizophrenia

Aug 9, 2006 - 12:37:00 PM , Reviewed by: Venkat Yelamanchili
The psychosis-inducing effect of ketamine is important evidence supporting the glutamate hypothesis of schizophrenia. This hypothesis, one of the leading neurochemical theories of schizophrenia, is based on the observation that glutamate antagonist drugs like ketamine induce symptoms similar to those of schizophrenia

 
[RxPG] Ketamine can induce symptoms of referential thinking, but not other symptoms of schizophrenia, according to a new study.

Ketamine is the structural analogue of the drug phencyclidine, now considered too toxic for experimental use in humans. In healthy volunteers, phencyclidine has been reported to induce paranoia, perceptual changes and other symptoms, including disorganisation of thought, negativism, apathy, withdrawal, poverty of speech and catatonia.

The psychosis-inducing effect of ketamine is important evidence supporting the glutamate hypothesis of schizophrenia. This hypothesis, one of the leading neurochemical theories of schizophrenia, is based on the observation that glutamate antagonist drugs like ketamine induce symptoms similar to those of schizophrenia

However, the symptoms the drug produces have not been described systematically. As the effects of ketamine are currently being characterised as a model of schizophrenia, it is important to document its psychopathological effects properly.

In this study, published in the August issue of the British Journal of Psychiatry, ketamine or a placebo was administered by continuous infusion to 15 healthy volunteers on 2 occasions, separated by at least 3 weeks.

While receiving ketamine at a set level, participants were interviewed to measure psychotic and non-psychotic symptoms; speech (for assessment of thought disorder); dissociation (e.g. ‘Do you feel disconnected from your own body?’); and also the negative symptoms of schizophrenia.

It was found that ketamine induced a range of perceptual distortions, but not visual or auditory hallucinations. Nearly half the people studied showed abnormal beliefs in the form of ‘referential ideas’, or delusions e.g. “I feel like a puppet…I feel like I’m the focus. Everyone is watching me.” There were only mild and infrequent ratings of thought disorder.

The authors comment that they were unable to replicate the finding that ketamine causes substantial levels of schizophrenia’s positive symptoms. Unchanging facial expression and other symptoms of ‘affective flattening’, plus another negative symptom, poverty nof speech, were found in over half the sample, where they were usually rated as mild or moderate.

Even so, they say, it is an open question whether ketamine genuinely induces the negative symptoms of schizophrenia, as it is possible that the changes observed were simply manifestations of ketamine’s general depressant effect on the central nervous system.

In summary, this study suggests that ketamine has a limited ‘psychotomimetic’ effect, which is most convincing with respect to an ability to induce referential beliefs similar to delusions.

Although ketamine does not reproduce the full picture of schizophrenia, the drug does seem to give rise to some of the symptoms, and it may prove useful in testing theories of specific symptoms such as delusions.



Publication: August issue of the British Journal of Psychiatry
On the web: bjp.rcpsych.org 

Advertise in this space for $10 per month. Contact us today.


Related Schizophrenia News
Nicotine may be a treatment for some symptoms of schizophrenia
People With Schizophrenia Face Increased Risk Of Diabetes - Research
Brain recruiting pattern incorrect in Schizophrenic patients
Schizophrenia Risk Gene DISC1 Plays a Broader Role in the Development of Nervous System
Chemical maps hint at drug's effects on schizophrenia
Study challenges idea that schizophrenia is distinct in developing and developed regions
New details in schizophrenia treatment trial emerge
Abnormalities in eye movements and attention can predict risk of Schizophrenia
Possible genetic link to schizophrenia identified
Brain scan may help doctors predict schizophrenia

Subscribe to Schizophrenia Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)